London · Delayed Price · Currency is GBP · Price in GBX GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 73.57 billion. The enterprise value is 88.81 billion.
| Market Cap | 73.57B |
| Enterprise Value | 88.81B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | May 14, 2026 |
Share Statistics
GSK plc has 3.99 billion shares outstanding. The number of shares has decreased by -1.13% in one year.
| Current Share Class | 3.99B |
| Shares Outstanding | 3.99B |
| Shares Change (YoY) | -1.13% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 86.82% |
| Float | 3.86B |
Valuation Ratios
The trailing PE ratio is 12.98 and the forward PE ratio is 10.08. GSK plc's PEG ratio is 1.75.
| PE Ratio | 12.98 |
| Forward PE | 10.08 |
| PS Ratio | 2.24 |
| PB Ratio | 4.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.54 |
| P/OCF Ratio | 9.51 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.63, with an EV/FCF ratio of 13.93.
| EV / Earnings | 15.24 |
| EV / Sales | 2.71 |
| EV / EBITDA | 7.63 |
| EV / EBIT | 8.97 |
| EV / FCF | 13.93 |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.10.
| Current Ratio | 0.79 |
| Quick Ratio | 0.51 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 1.64 |
| Debt / FCF | 3.00 |
| Interest Coverage | 14.94 |
Financial Efficiency
Return on equity (ROE) is 40.91% and return on invested capital (ROIC) is 26.70%.
| Return on Equity (ROE) | 40.91% |
| Return on Assets (ROA) | 10.02% |
| Return on Invested Capital (ROIC) | 26.70% |
| Return on Capital Employed (ROCE) | 24.49% |
| Weighted Average Cost of Capital (WACC) | 5.29% |
| Revenue Per Employee | 490,418 |
| Profits Per Employee | 87,207 |
| Employee Count | 66,841 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.46 |
Taxes
In the past 12 months, GSK plc has paid 1.08 billion in taxes.
| Income Tax | 1.08B |
| Effective Tax Rate | 14.54% |
Stock Price Statistics
The stock price has increased by +33.65% in the last 52 weeks. The beta is 0.30, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +33.65% |
| 50-Day Moving Average | 2,053.10 |
| 200-Day Moving Average | 1,799.06 |
| Relative Strength Index (RSI) | 27.08 |
| Average Volume (20 Days) | 6,646,651 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 32.78 billion and earned 5.83 billion in profits. Earnings per share was 1.42.
| Revenue | 32.78B |
| Gross Profit | 23.89B |
| Operating Income | 9.91B |
| Pretax Income | 7.44B |
| Net Income | 5.83B |
| EBITDA | 11.43B |
| EBIT | 9.91B |
| Earnings Per Share (EPS) | 1.42 |
Balance Sheet
The company has 3.44 billion in cash and 19.11 billion in debt, with a net cash position of -15.67 billion or -3.93 per share.
| Cash & Cash Equivalents | 3.44B |
| Total Debt | 19.11B |
| Net Cash | -15.67B |
| Net Cash Per Share | -3.93 |
| Equity (Book Value) | 17.42B |
| Book Value Per Share | 4.44 |
| Working Capital | -4.67B |
Cash Flow
In the last 12 months, operating cash flow was 7.74 billion and capital expenditures -1.36 billion, giving a free cash flow of 6.38 billion.
| Operating Cash Flow | 7.74B |
| Capital Expenditures | -1.36B |
| Depreciation & Amortization | 1.53B |
| Net Borrowing | 533.00M |
| Free Cash Flow | 6.38B |
| FCF Per Share | 1.60 |
Margins
Gross margin is 72.87%, with operating and profit margins of 30.22% and 17.78%.
| Gross Margin | 72.87% |
| Operating Margin | 30.22% |
| Pretax Margin | 22.69% |
| Profit Margin | 17.78% |
| EBITDA Margin | 34.88% |
| EBIT Margin | 30.22% |
| FCF Margin | 19.45% |
Dividends & Yields
This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 3.91%.
| Dividend Per Share | 0.72 |
| Dividend Yield | 3.91% |
| Dividend Growth (YoY) | 8.06% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 44.52% |
| Buyback Yield | 1.13% |
| Shareholder Yield | 5.03% |
| Earnings Yield | 7.92% |
| FCF Yield | 8.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 2.09 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.09 |
| Piotroski F-Score | 7 |